Literature DB >> 27603742

Evidence-Based Treatments for Borderline Personality Disorder: Implementation, Integration, and Stepped Care.

Lois W Choi-Kain1, Elizabeth B Albert, John G Gunderson.   

Abstract

LEARNING
OBJECTIVE: After participating in this activity, learners should be better able to:• Evaluate evidence-based therapies for borderline personality disorder ABSTRACT: Several manualized psychotherapies for treating borderline personality disorder (BPD) have been validated in randomized, controlled trials. Most of these approaches are highly specialized, offering different formulation of BPD and different mechanisms by which recovery is made possible. Mental health clinicians are challenged by the degree of specialization and clinical resources that these approaches require in their empirically validated adherent forms. While these effective treatments have renewed optimism for the treatment of BPD, clinicians may feel limited in their ability to offer any of them or may integrate an eclectic assortment of features from the different treatments. This article will evaluate four major evidence-based treatments for BPD-dialectical behavioral therapy, mentalization-based treatment, transference-focused psychotherapy, and General Psychiatric Management-and possible modes of implementation in adherent and integrative forms. Models of implementing these diverse treatment approaches will be evaluated, and the potential advantages of combining evidence-based treatments will be discussed, along with some cautionary notes. A proposal for providing stepwise care through assessment of clinical severity will be presented as a means of achieving system-wide changes and greater access to care.

Entities:  

Mesh:

Year:  2016        PMID: 27603742     DOI: 10.1097/HRP.0000000000000113

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  8 in total

Review 1.  Diagnosis and Treatment of Borderline Personality Disorder in the College Mental Health Setting.

Authors:  Claire M Brickell
Journal:  Curr Psychiatry Rep       Date:  2018-05-18       Impact factor: 5.285

2.  Filling the gap between theory and practice: A pilot study on parents' perceptions of integrated care for patients with borderline personality disorder.

Authors:  Irene Gabutti
Journal:  Int J Health Plann Manage       Date:  2021-08-30

3.  Lessening of the pervasiveness of interpersonal patterns in borderline personality disorder explains symptom decrease after treatment: A process analysis.

Authors:  Ueli Kramer; Hélène Beuchat; Loris Grandjean; Federico Seragnoli; Slimane Djillali; Chloe Choffat; Elisa George; Jean-Nicolas Despland; Stéphane Kolly; Yves de Roten
Journal:  J Clin Psychol       Date:  2021-11-04

Review 4.  What Works in the Treatment of Borderline Personality Disorder.

Authors:  Lois W Choi-Kain; Ellen F Finch; Sara R Masland; James A Jenkins; Brandon T Unruh
Journal:  Curr Behav Neurosci Rep       Date:  2017-02-03

5.  A double-blind placebo-controlled study of brexpiprazole for the treatment of borderline personality disorder.

Authors:  Jon E Grant; Stephanie Valle; Eve Chesivoir; Dustin Ehsan; Samuel R Chamberlain
Journal:  Br J Psychiatry       Date:  2021-11-17       Impact factor: 9.319

6.  Key stakeholders' experiences and expectations of the care system for individuals affected by borderline personality disorder: An interpretative phenomenological analysis towards co-production of care.

Authors:  Laura Friesen; Graham Gaine; Ellen Klaver; Lisa Burback; Vincent Agyapong
Journal:  PLoS One       Date:  2022-09-22       Impact factor: 3.752

7.  Effects of substance use disorder on treatment process and outcome in a ten-session psychiatric treatment for borderline personality disorder.

Authors:  Louise Penzenstadler; Stéphane Kolly; Stéphane Rothen; Yasser Khazaal; Ueli Kramer
Journal:  Subst Abuse Treat Prev Policy       Date:  2018-02-26

8.  Mechanisms of change in brief treatments for borderline personality disorder: a protocol of a randomized controlled trial.

Authors:  Ueli Kramer; Loris Grandjean; Hélène Beuchat; Stéphane Kolly; Philippe Conus; Yves de Roten; Bogdan Draganski; Jean-Nicolas Despland
Journal:  Trials       Date:  2020-04-16       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.